Boothbay Fund Management, LLC Procept Bio Robotics Corp Transaction History
Boothbay Fund Management, LLC
- $3.6 Billion
- Q3 2024
A detailed history of Boothbay Fund Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 14,300 shares of PRCT stock, worth $994,708. This represents 0.03% of its overall portfolio holdings.
Number of Shares
14,300Holding current value
$994,708% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PRCT
# of Institutions
277Shares Held
39.5MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$337 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$242 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$107 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$86.5 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$82 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.1B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...